{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Running&page=13", "query": { "intervention": "Running", "page": 13 }, "page_size": 10 }, "pagination": { "page": 13, "page_size": 10, "total_count": 1411, "total_pages": 142, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Running&page=14&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Running&page=12&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-18T10:55:37.197Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06095297", "title": "Long COVID Brain Fog: Cognitive Rehabilitation Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Long COVID", "Brain Fog", "Cognitive Impairment", "Cognitive Dysfunction", "Post-Acute COVID-19 Syndrome" ], "interventions": [ { "name": "Processing Speed Training", "type": "BEHAVIORAL" }, { "name": "In-lab Instrumental Activities of Daily Living Training", "type": "BEHAVIORAL" }, { "name": "In-lab Brain Health Training", "type": "BEHAVIORAL" }, { "name": "Transfer Package", "type": "BEHAVIORAL" }, { "name": "Follow Up Phone Calls", "type": "BEHAVIORAL" }, { "name": "Vocational Rehabilitation", "type": "BEHAVIORAL" }, { "name": "Peer Mentoring", "type": "BEHAVIORAL" }, { "name": "Reaction Time Training", "type": "BEHAVIORAL" }, { "name": "Trans-auricular Vagus Nerve Stimulation: High Intensity", "type": "PROCEDURE" }, { "name": "Trans-auricular Vagus Nerve Stimulation: Low Intensity", "type": "PROCEDURE" } ], "intervention_types": [ "BEHAVIORAL", "PROCEDURE" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2024-04-25", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-10-18T10:55:37.197Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT06095297" }, { "nct_id": "NCT03525548", "title": "A Study of VX-445 Combination Therapy in CF Subjects Homozygous for F508del (F/F)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "VX-445/TEZ/IVA", "type": "DRUG" }, { "name": "TEZ/IVA", "type": "DRUG" }, { "name": "IVA", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vertex Pharmaceuticals Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 113, "start_date": "2018-08-03", "completion_date": "2018-12-28", "has_results": true, "last_update_posted_date": "2020-01-27", "last_synced_at": "2026-10-18T10:55:37.197Z", "location_count": 28, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Long Beach, California + 24 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Madera", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03525548" }, { "nct_id": "NCT04827576", "title": "Study of Magrolimab in Patients With Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Solid Tumor" ], "interventions": [ { "name": "Magrolimab", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 106, "start_date": "2021-10-01", "completion_date": "2024-10-01", "has_results": true, "last_update_posted_date": "2025-05-08", "last_synced_at": "2026-10-18T10:55:37.197Z", "location_count": 21, "location_summary": "Goodyear, Arizona • La Jolla, California • Santa Monica, California + 17 more", "locations": [ { "city": "Goodyear", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "Deerfield Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04827576" }, { "nct_id": "NCT05076149", "title": "A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "VX-121/TEZ/D-IVA", "type": "DRUG" }, { "name": "ELX/TEZ/IVA", "type": "DRUG" }, { "name": "IVA", "type": "DRUG" }, { "name": "Placebo (matched to VX-121/TEZ/D-IVA)", "type": "DRUG" }, { "name": "Placebo (matched to ELX/TEZ/IVA)", "type": "DRUG" }, { "name": "Placebo (matched to IVA)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vertex Pharmaceuticals Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 597, "start_date": "2021-10-27", "completion_date": "2023-11-30", "has_results": true, "last_update_posted_date": "2024-06-13", "last_synced_at": "2026-10-18T10:55:37.197Z", "location_count": 62, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 55 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05076149" }, { "nct_id": "NCT01725126", "title": "To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "GSK2890457", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Liraglutide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 53, "start_date": "2013-02-10", "completion_date": "2013-09-12", "has_results": true, "last_update_posted_date": "2017-12-13", "last_synced_at": "2026-10-18T10:55:37.197Z", "location_count": 3, "location_summary": "Chula Vista, California • Miami, Florida • Overland Park, Kansas", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01725126" }, { "nct_id": "NCT06926855", "title": "Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Uncontrolled Diabetes", "Uncontrolled Hypertension" ], "interventions": [ { "name": "CHC-level cluster randomized control trial", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Morehouse School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72726, "start_date": "2025-05-01", "completion_date": "2026-05-29", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-10-18T10:55:37.197Z", "location_count": 3, "location_summary": "Miami, Florida • Atlanta, Georgia • Portland, Oregon", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT06926855" }, { "nct_id": "NCT01543633", "title": "EEG Studies of Induction and Recovery From Propofol Induced General Anesthesia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Brain Activity Under Sedation" ], "interventions": [ { "name": "Propofol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "36 Years", "sex": "ALL", "summary": "18 Years to 36 Years" }, "enrollment_count": 36, "start_date": "2005-08", "completion_date": "2020-07", "has_results": true, "last_update_posted_date": "2022-01-11", "last_synced_at": "2026-10-18T10:55:37.197Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01543633" }, { "nct_id": "NCT01242371", "title": "Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder" ], "interventions": [ { "name": "Probiotic Supplement", "type": "DIETARY_SUPPLEMENT" }, { "name": "Identical-appearing Placebo", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Sheppard Pratt Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 65, "start_date": "2010-08", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2019-02-05", "last_synced_at": "2026-10-18T10:55:37.197Z", "location_count": 1, "location_summary": "Towson, Maryland", "locations": [ { "city": "Towson", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01242371" }, { "nct_id": "NCT03530852", "title": "A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Short Bowel Syndrome", "Malabsorption" ], "interventions": [ { "name": "Relizorb", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Years to 18 Years" }, "enrollment_count": 32, "start_date": "2018-11-21", "completion_date": "2028-09-30", "has_results": false, "last_update_posted_date": "2026-08-03", "last_synced_at": "2026-10-18T10:55:37.197Z", "location_count": 2, "location_summary": "Los Angeles, California • Boston, Massachusetts", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03530852" }, { "nct_id": "NCT04351087", "title": "Microfragmented Adipose Tissue Versus Platelet-rich Plasma for Knee Osteoarthritis: a Randomized Comparative Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis, Knee", "Microfragmented Adipose Tissue", "Platelet-Rich Plasma" ], "interventions": [ { "name": "Platelet Rich Plasma", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "25 Years to 75 Years" }, "enrollment_count": 79, "start_date": "2020-03-03", "completion_date": "2022-07-05", "has_results": true, "last_update_posted_date": "2024-08-09", "last_synced_at": "2026-10-18T10:55:37.197Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04351087" } ] }